DCT

1:24-cv-01011

Endocyte Inc v. Point Biopharma Global Inc

General
Filed
06/13/24
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
71%